Latest ebit for HNGR: $69M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 30, 2022
Trailing 12 months ending Jun 30, 2022
The latest EBIT for HNGR is $69M as of June 2022. That compares with $64M in the prior-year period — up 6.9% year over year. That is below the Healthcare sector average of $23B. Investors often review this figure alongside Hanger's historical trend and sector peers before judging valuation or financial health.
Over the past year, HNGR's EBIT moved from $64M to $69M — a 6.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Hanger's operating scale or balance-sheet position.
Against Healthcare companies, HNGR currently prints $69M for EBIT, while the sector average sits near $23B. That is roughly 99.7% below the sector mean. Large gaps often invite a closer look at Hanger's growth, margins, and balance sheet.
A EBIT figure of $69M for HNGR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $23B. Explore the charts below for those layers of context.
After noting HNGR's EBIT ($69M), review year-over-year change from $64M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.